// App-Quantinova.ai

198 : Selecting the optimal neoadjuvant treatment approach based on the risk of an involved surgical margin in locally advanced adenocarcinoma of the esophagus and esophagogastric junction.

Researchers

Presenter

  • Tim Spencer

Principal Investigators

  • Jonathan Helbrow

  • Eleanor Pilsworth

  • Stephen Falk

  • Helen Winter

  • Thomas Bird

Medical Centers

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved